Trials / Completed
CompletedNCT00713609
Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With Acne
A Multi-center, Randomized, Double-blind, Vehicle-Controlled, Phase 2 Study of the Safety and Efficacy of Benzoyl Peroxide/Clindamycin Gel and Tazarotene Cream When Used in Combination in the Treatment of Acne Vulgaris
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 591 (actual)
- Sponsor
- Stiefel, a GSK Company · Industry
- Sex
- All
- Age
- 12 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
Benzoyl peroxide, clindamycin and tazarotene are known to be effective treatment alternative for acne vulgaris. The purpose of this study is to assess the safety and efficacy of a combination product including these actives for the treatment of acne vulgaris. You may be suitable to take part in this study because you have acne vulgaris on your face. Acne vulgaris usually affects the face, but it can also affect the skin on the chest, arms, legs, and back.
Detailed description
The study subjects must have acne vulgaris and will apply study drug to their face for 12 weeks. Study visits will occur at baseline (day 1) and at weeks 2, 4, 8, and 12. Subjects will be assessed at every visit to determine how the study drug is working. Safety will be assessed by evaluation of adverse events (AEs), vital signs, physical examinations, and withdrawals from the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Benzoyl peroxide gel | 5% benzoyl peroxide in a gel applied topically once a day |
| DRUG | Clindamycin gel | 1% clindamycin phosphate applied topically once a day |
| DRUG | Tazarotene cream | 0.1 % tazarotene in a cream applied topically once a day |
| DRUG | Vehicle gel | Vehicle gel is an identical gel without the active ingredients |
| DRUG | Vehicle cream | Vehicle cream is an identical cream without the active ingredients |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2009-03-01
- Completion
- 2009-03-01
- First posted
- 2008-07-11
- Last updated
- 2017-03-06
- Results posted
- 2017-03-06
Locations
16 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00713609. Inclusion in this directory is not an endorsement.